Clinical trials
Terminated Phase 2 Cytokine Release Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 10 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 101 Therapeutics | 1 |
| Ashvattha Therapeutics, Inc. | 1 |
| Boston Medical Center | 1 |
| Corewell Health East | 1 |
| Hospital General de México Dr. Eduardo Liceaga | 1 |
| Hospital Sao Domingos | 1 |
| Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 1 |
| Johns Hopkins University | 1 |
| Olatec Therapeutics, Inc. | 1 |
| PhaseBio Pharmaceuticals Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cytokine Release Syndrome | 12 |
| COVID-19 | 10 |
| Coronavirus Infections | 6 |
| Respiratory Distress Syndrome | 4 |
| Inflammation | 2 |
| Angioedemas, Hereditary | 1 |
| Cardiovascular Diseases | 1 |
| Communicable Diseases | 1 |
| Dyspnea | 1 |
| Heart Failure | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.